title: Early experience using calcineurin-free protocol in recipients of high-risk cadaver renal transplants.
authors.affiliation: Departments of Transplantation/Vascular Surgery, New York Medical College, Valhalla, New York, USA.
authors.forename: R
authors.initials: R
authors.lastname: El-Sabrout
authors.forename: V
authors.initials: V
authors.lastname: Delaney
authors.forename: F
authors.initials: F
authors.lastname: Butt
authors.forename: M
authors.initials: M
authors.lastname: Qadir
authors.forename: I
authors.initials: I
authors.lastname: Rashid
authors.forename: P
authors.initials: P
authors.lastname: Hanson
authors.forename: K
authors.initials: K
authors.lastname: Butt
mesh_terms: D002102:Cadaver; D019703:Calcineurin; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D009518:New York; D044469:Racial Groups; D018570:Risk Assessment; D020123:Sirolimus / Q000627:therapeutic use*; D013997:Time Factors; D014019:Tissue Donors
chemical_list: D007166:Immunosuppressive Agents; D019703:Calcineurin; D009173:Mycophenolic Acid; D020123:Sirolimus